Literature DB >> 6644560

Distribution and elimination of poly(methyl methacrylate) nanoparticles after subcutaneous administration to rats.

J Kreuter, M Nefzger, E Liehl, R Czok, R Voges.   

Abstract

Poly(methyl [1-14C]methacrylate) nanoparticles were injected subcutaneously into rats. Almost all of the radioactivity stayed at the injection site. After an initial urinary and fecal excretion of approximately 1% of the administered dose per day, the rate of elimination dropped to a low level (approximately 0.005%/day via the feces and approximately 0.0005%/day via the urine) within 70 days. After 200 days, the fecal elimination increased exponentially until a greater than 100-fold increase was observed after 287 days in one rat. After this time, a tendency for an increase in fecal elimination was also observed in the other animals, and the radioactivity in all organs and tissue increased by approximately 100 times in all animals in comparison with the organ radioactivity determinations at earlier times.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644560     DOI: 10.1002/jps.2600721009

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

Review 1.  A holistic approach to targeting disease with polymeric nanoparticles.

Authors:  Christopher J Cheng; Gregory T Tietjen; Jennifer K Saucier-Sawyer; W Mark Saltzman
Journal:  Nat Rev Drug Discov       Date:  2015-01-19       Impact factor: 84.694

Review 2.  Hurdle technology using encapsulated enzymes and essential oils to fight bacterial biofilms.

Authors:  Samah Mechmechani; Simon Khelissa; Adem Gharsallaoui; Khaled El Omari; Monzer Hamze; Nour-Eddine Chihib
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-21       Impact factor: 4.813

3.  Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats.

Authors:  P Maincent; P Thouvenot; C Amicabile; M Hoffman; J Kreuter; P Couvreur; J P Devissaguet
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.